Neurologic Outcomes in People with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Exposed To Immune Checkpoint Inhibitors
Dr. Shuvro Roy and Dr. Alexander Gill discuss his paper "Neurologic Outcomes in People with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Exposed To Immune Checkpoint Inhibitors."…
Read the full articleYou might also wanna read
Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Refractory Autoimmune Encephalitis and Autoimmune Cerebellitis
Conditions : Autoimmune Encephalitis (AE); Autoimmune Cerebellitis Interventions : Drug: Blinatumomab Sponsors : Beijing Tiantan Hospital No
Does Epstein-Barr virus lead to multiple sclerosis?
Interview with Corey McGraw, MD
Riptylimab for the Treatment of Optic Neuritis and Myelitis Spectrum Diseases
Conditions : Neuromyelitis Optica Spectrum Disease (NMOSD); Ripertamab Interventions : Drug: Riptylimab Sponsors : Zhongming Qiu Not yet rec
Rethinking prognosis in multiple sclerosis: a multiaxial perspective
Revolutionize MS prognosis—integrate lesion burden, neuroaxonal injury, compensatory mechanisms. Unite diverse factors! PMID:42156973, Nat R
ClinicalTrials.gov
New clinical trial Disability Progression in Multiple Sclerosis: Determinants, Pathophysiology, and Global Health Impact #ClinicalTrials #Mu
clinicaltrials.gov·1mo ago
STAT+: New study untangles how Epstein-Barr viral infection triggers immune response in multiple sclerosis
A new study claims to have uncovered how Epstein-Barr virus launches immune responses seen in people with multiple sclerosis.
Comments
Sign in to join the conversation.
No comments yet. Be the first.